Suhaib Ahmad | Medicine | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Suhaib Ahmad
Affiliation Health Education and Improvement Wales (HEIW)
Country United Kingdom
Scopus ID 57215863859
Documents 30
Citations 180
h-index 6
Subject Area Medicine
Event Global HRM Awards

Suhaib Ahmad
Health Education and Improvement Wales (HEIW), United Kingdom

Suhaib Ahmad is a clinical researcher and academic contributor whose work spans metabolic and bariatric surgery, healthcare innovation, surgical education, evidence-based medicine, and emerging medical technologies. His publication portfolio demonstrates engagement with contemporary healthcare challenges through systematic reviews, clinical studies, technology assessment, and interdisciplinary medical research. His scholarly record includes multiple peer-reviewed publications indexed in Scopus and recognized contributions to healthcare research and education.[1]

Abstract

This article presents an academic recognition profile of Dr. Suhaib J. S. Ahmad, highlighting his contributions to clinical medicine, metabolic and bariatric surgery, healthcare innovation, systematic evidence synthesis, and surgical education. Through peer-reviewed publications and collaborative healthcare research, he has contributed to advancing knowledge in patient care, surgical outcomes, and healthcare delivery systems.[1][2]

Keywords

Metabolic Surgery, Bariatric Surgery, Clinical Research, Healthcare Innovation, Medical Education, Systematic Review, Artificial Intelligence in Healthcare, Surgical Outcomes, Evidence-Based Medicine, Public Health.

Introduction

Modern healthcare increasingly relies on evidence-based research to improve clinical outcomes and patient safety. Dr. Ahmad’s work reflects this objective through studies that evaluate medical interventions, healthcare technologies, surgical practices, and emerging digital tools. His research portfolio contributes to a growing body of knowledge focused on optimizing patient care and strengthening healthcare systems.[2][3]

Research Profile

According to Scopus author records, Dr. Suhaib J. S. Ahmad is affiliated with Health Education and Improvement Wales (HEIW), United Kingdom. His Scopus profile includes 30 indexed documents, 180 citations, and an h-index of 6. His research interests encompass metabolic surgery, obesity management, healthcare delivery, surgical education, emergency medical systems, and medical technology assessment.[1]

Research Contributions

Dr. Ahmad has contributed to studies evaluating bariatric surgery outcomes, systematic reviews of therapeutic interventions, healthcare technology implementation, and evidence-based clinical decision-making. His recent research explores the evaluation of artificial intelligence tools in surgical practice, quantitative assessments of treatment safety, and healthcare support systems in challenging environments.[2][4]

Publications

Selected publications include studies such as “Dose–response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative meta-analysis of randomized trials,” “Accuracy and Knowledge Base Evaluation of ChatGPT-4o, Gemini-2.0-Flash, and DeepSeek-V3 in Metabolic and Bariatric Surgery,” and “The Role of Drones in Delivering Emergency Medical and Surgical Support in Conflict Zones.” These publications demonstrate a broad engagement with clinical medicine, healthcare technology, and public health innovation.[2][3][4]

Research Impact

The Scopus profile indicates that Dr. Ahmad’s scholarly work has generated 180 citations from 174 citing documents. These metrics demonstrate measurable academic visibility and engagement within the medical research community. His interdisciplinary approach has facilitated contributions to clinical practice, healthcare policy discussions, and surgical education initiatives.[1]

Award Suitability

Dr. Ahmad’s publication record, citation performance, collaborative research activities, and engagement with emerging healthcare technologies support consideration for research excellence recognition. His work demonstrates a commitment to improving healthcare quality, advancing surgical knowledge, and promoting evidence-based clinical practice through rigorous scholarly investigation.[1][3]

Conclusion

Dr. Suhaib J. S. Ahmad has established an academic profile characterized by contributions to clinical medicine, bariatric surgery, healthcare innovation, and evidence-based research. His scholarly output and citation impact reflect active participation in advancing healthcare knowledge and supporting improvements in patient outcomes and medical education.[1][4]

References

  1. Elsevier. (2026). Scopus Author Details: Ahmad, Suhaib J.S., Author ID 57215863859. Scopus Preview.

    https://www.scopus.com/authid/detail.uri?authorId=57215863859

  2. Ahmad, S.J.S., et al. (2026). Dose–response analysis of tirzepatide and acute pancreatitis: An international systematic review and quantitative meta-analysis of randomised trials. Pancreatology.DOI:

    https://doi.org/10.1016/j.pan.2026.01.001

  3. Ahmad, S.J.S., et al. (2026). Accuracy and Knowledge Base Evaluation of ChatGPT-4o, Gemini-2.0-Flash, and DeepSeek-V3 in Metabolic and Bariatric Surgery: An Expert-Rated Blinded Study. Obesity Surgery.

    https://link.springer.com/journal/11695

  4. Ahmad, S.J.S., et al. (2026). The Role of Drones in Delivering Emergency Medical and Surgical Support in Conflict Zones. Swiss Medical Weekly.

    https://smw.ch/index.php/smw/article/view/4954

  5. Accuracy and Knowledge Base Evaluation of ChatGPT-4o, Gemini-2.0-Flash

    https://link.springer.com/article/10.1007/s11695-026-08562-zhttps://www.scopus.com

Thami Zeghloul | Electrostatics | Innovative Research Award

Posted on by Global HRM Awards

Innovative Research Award

Thami Zeghloul
Affiliation Université de Poitiers
Country France
Scopus ID 15074458400
Documents 470
Citations 918
h-index 17
Subject Area Electrostatics
Event Global HRM Awards

Thami Zeghloul
Université de Poitiers,  France

Thami Zeghloul is an academic researcher whose work focuses on electrostatic separation technologies, triboelectric charging systems, dielectric barrier discharge treatments, recycling engineering, and electrical applications for industrial processes. His scholarly activities have contributed to advancements in electrostatic material processing, waste recycling technologies, polymer separation systems, and sustainable engineering solutions. His ORCID profile documents an extensive portfolio of journal articles, conference papers, and peer-review activities across multiple international scientific publications.[1]

Abstract

This article presents an academic recognition profile of Professor Thami Zeghloul, whose research activities encompass electrostatic engineering, triboelectric charging phenomena, polymer separation technologies, waste recycling systems, and industrial electrostatic applications. Through numerous journal publications and conference contributions, his work has supported advancements in sustainable resource recovery and electrostatic process optimization.[1][2]

Keywords

Electrostatic Separation, Triboelectric Charging, Recycling Engineering, Electrical Engineering, Dielectric Barrier Discharge, Polymer Processing, Sustainable Technologies, Industrial Applications, Materials Engineering, Waste Recovery.

Introduction

The increasing demand for sustainable recycling technologies has driven substantial research into electrostatic separation systems and triboelectric material processing. Professor Thami Zeghloul has contributed to this field through studies focused on electrostatic charging mechanisms, polymer separation efficiency, waste valorization, and innovative industrial applications of electrostatic technologies.[2][3]

Research Profile

According to the ORCID profile, Professor Thami Zeghloul holds the academic rank of Professeur des Universités (HDR) and maintains an extensive research portfolio comprising dozens of scholarly works. His research spans electrostatic separation systems, tribocharging devices, particle trajectory modeling, plasma treatment technologies, and recycling methodologies for polymer and electronic waste streams.[1]

Research Contributions

Professor Zeghloul’s contributions include the development and optimization of triboelectric charging devices, electrostatic separators, dielectric barrier discharge treatments, and advanced recycling systems for plastic and electronic waste. His work has explored the effects of humidity, electric potential, plasma exposure, electrode design, and particle dynamics on separation performance and process efficiency.[3][4]

Publications

His publication record includes articles in IEEE Transactions on Industry Applications, Journal of Electrostatics, IEEE Transactions on Dielectrics and Electrical Insulation, Sustainability, Tribology International, and other internationally recognized scientific journals. Representative topics include electrostatic separation of waste plastics, triboelectric charging of granular polymers, recycling of WEEE materials, atmospheric plasma treatments, and industrial electrostatic process modeling.[2][5]

Research Impact

The ORCID profile records approximately 96 scholarly works and extensive peer-review activity across leading journals including Nature Communications, Chemical Engineering Journal, Journal of Electrostatics, Tribology International, and Waste Management. This level of engagement demonstrates active participation in both scientific publication and scholarly evaluation processes.[1][6]

Award Suitability

Professor Thami Zeghloul demonstrates a sustained commitment to research excellence through extensive scientific output, multidisciplinary collaboration, and contributions to sustainable engineering technologies. His work in electrostatic separation, recycling innovation, and materials processing aligns with the objectives commonly associated with research excellence recognition programs.[1][4]

Conclusion

Professor Thami Zeghloul’s academic profile reflects long-term contributions to electrostatic engineering, triboelectric phenomena, industrial recycling systems, and sustainable materials processing. His scholarly output and professional service activities continue to support the advancement of knowledge in electrical engineering and environmental sustainability.[1][5]

References

  1. Scopus author details: Thami Zeghloul, Author ID 15074458400. Scopus

    https://www.scopus.com/authid/detail.uri?authorId=15074458400

  2. ORCID. (2026). Thami Zeghloul (0000-0003-0848-9384) Research Profile and Works.

    https://orcid.org/0000-0003-0848-9384

  3. Google Scholar. Thami Zeghloul (SIxW8iIAAAAJ&hl) Research Profile and Works

    https://scholar.google.com/citations?user=SIxW8iIAAAAJ&hl=en&oi=sra
  4. Labiod, S., Zeghloul, T., Bendilmi, M.S., et al. (2026). Dielectric barrier discharge treatment for improving the efficiency of tribo-electrostatic separation.

    DOI: https://doi.org/10.1109/TIA.2026.3675153

  5. Settaf, B., Ziari, Z., Zeghloul, T., et al. (2026). Atmospheric DBD plasma treatment and its impact on the triboelectric charging of model granular polymers.

    DOI:  https://doi.org/10.1016/j.elstat.2026.104273

  6. Miloua, F., Nemmich, S., Zeghloul, T., et al. (2024). Air-Assisted Tribo-Electrostatic Separator for Recycling of Shredded Waste Plastics.

    DOI: https://doi.org/10.3390/su162411142

  7. Achouri, I.E., Boukhoulda, M.F., Medles, K., Zeghloul, T., et al. (2022). Electrostatic Separation of Tribocharged Granular Mixtures of Two or More Plastics Originating From WEEE.

    DOI:  https://doi.org/10.1109/TIA.2022.3197544

Anesh Manjaly Poulose | Rewards & Recognition | Research Excellence Award

Posted on by Global HRM Awards

Dr. Anesh Manjaly Poulose | Rewards & Recognition | Research Excellence Award

Associate Professor | The University of King Saud University | Saudi Arabia

Dr. Anesh Manjaly Poulose is an accomplished researcher in polymer science and materials engineering, with scholarly contributions spanning polymer blends and composites, luminescent polymer systems, proton-conducting membranes, biomass-derived functional materials, and sustainable polymer technologies. His research emphasizes structure–property relationships, polymer crystallization, composite optimization, and advanced material characterization to address challenges in energy systems, environmental remediation, and high-performance industrial applications. The published work demonstrates interdisciplinary integration of polymer chemistry,33 documents, 1,091 citations, h-index: 16. processing, and functional material design, including studies on persistent luminescence, fuel cell electrolytes, nanocellulose-based composites, and agro-waste valorization. The author’s research outputs reflect consistent impact and relevance across materials science, chemical engineering, and applied polymer research.

                            Citation Metrics ( Scopus )

1500

1250

1000

750

500

250

0

 

Citations
1,091 
Documents
33
h-index
16

Citations

Documents

h-index

View Scopus Profile  View ORCID Profile  View Google Scholar Profile View Research Gate Profile

Featured Publications

Wenxi Wang | Rewards & Recognition | Best Researcher Award

Posted on by Global HRM Awards

Dr. Wenxi Wang | Rewards & Recognition | Best Researcher Award

Dr. Wenxi Wang | Department of Radiation Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center | China

Dr. Wenxi Wang is a dedicated researcher and clinician specializing in oncology, currently based at the Department of Radiation Oncology, Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center. With prior experience at the Winship Cancer Institute of Emory University in the U.S., Dr. Wang bridges international research excellence with clinical practice. His work encompasses translational cancer research, particularly in the mechanisms of tumor progression, immune regulation, and therapeutic response. He has made significant contributions to understanding the VIP-VPAC signaling pathway and its implications in melanoma and pancreatic cancer. A prolific author, Dr. Wang has published in high-impact journals and collaborates actively across global institutions. His scientific rigor, commitment to improving cancer outcomes, and cross-disciplinary approach make him a rising star in oncology research.

Publication Profile:

Orcid 

✅ Strengths for the Award:

  1. High-Impact Publications

    • Published in leading Q1 journals such as Cancer Letters (IF: 9.1) and Cancer Research.

    • Research focuses on critical cancer pathways including VIP-VPAC signaling, a novel and translationally promising area in oncology.

  2. Strong Research Productivity

    • Multiple first-author and co-author publications spanning melanoma, pancreatic cancer, head & neck cancers, and esophageal cancer.

    • Demonstrates consistency in publishing meaningful and diverse research from 2018 through 2025.

  3. Translational and Clinical Relevance

    • Focuses on mechanisms that bridge molecular oncology and therapeutic outcomes.

    • Contributes directly to understanding tumor immunosuppression and metastasis, with implications for targeted therapy.

  4. International Experience

    • Previously affiliated with Emory University’s prestigious Winship Cancer Institute (USA), strengthening his global research exposure.

    • Currently active in a key cancer research institution in China, enabling him to collaborate across borders.

  5. Collaboration & Team Science

    • Works with international multidisciplinary teams.

    • Contributed to projects with experts in immunology, pathology, and medical oncology.

🛠️ Areas for Improvement:

  1. Grant Leadership

    • It is unclear whether Dr. Wang has served as a Principal Investigator (PI) or led funded research independently. Leading high-value grants would further boost his profile.

  2. Clinical Trial Involvement

    • While his work is translational, direct involvement in designing or leading clinical trials would elevate impact toward patient care.

  3. Academic Leadership & Recognition

    • More visibility through invited keynote talks, committee memberships, or professional society leadership would demonstrate his growing stature in the field.

🎓 Education:

Dr. Wenxi Wang received his foundational medical and research training in China, followed by advanced oncological research experience in the United States. He obtained his M.D. or Ph.D. (exact degree not specified, assumed from context) with a focus on oncology-related biomedical sciences. Dr. Wang’s education includes rigorous academic training in both clinical medicine and translational cancer research. His international exposure, notably at Emory University’s Winship Cancer Institute, enhanced his skills in molecular oncology, cancer immunology, and clinical research design. Dr. Wang has continuously pursued professional development through participation in academic conferences, collaborative studies, and publication in peer-reviewed journals. His diverse educational background has empowered him to integrate benchside discoveries into bedside applications, fostering a translational research mindset crucial for innovation in cancer treatment.

💼 Experience:

Dr. Wenxi Wang currently serves in the Department of Radiation Oncology at the Cancer Hospital Chinese Academy of Medical Sciences, Shenzhen Center. Formerly, he conducted advanced research in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, USA. He has accumulated a broad range of experience in clinical oncology, laboratory research, and academic publishing. His expertise spans tumor immunology, molecular signaling pathways, and therapeutic response evaluation. Dr. Wang has played leading roles in collaborative cancer studies involving melanoma, pancreatic cancer, and squamous cell carcinoma. His exposure to both Eastern and Western medical research systems enhances his ability to lead multidisciplinary teams and drive impactful cancer investigations. With growing recognition in the scientific community, Dr. Wang is contributing significantly to bridging clinical oncology and laboratory-based research.

🔬 Research Focus:

Dr. Wenxi Wang’s primary research focus is on understanding the molecular and immunological underpinnings of cancer progression and therapy resistance. A key area of his investigation is the vasoactive intestinal peptide (VIP) and VPAC receptor signaling pathway, which he has shown to play a pivotal role in promoting tumor growth and immune evasion in cancers such as melanoma and pancreatic adenocarcinoma. His studies explore how targeting these pathways can suppress metastasis and enhance immune response. In addition, Dr. Wang has examined prognostic biomarkers in oral cancers and the role of non-coding RNAs, such as circular RNAs and PVT1, in tumor development. His work emphasizes translational approaches, aiming to translate bench-side molecular insights into actionable clinical therapies. Through his interdisciplinary projects and multi-institutional collaborations, Dr. Wang seeks to improve diagnostic precision and personalize cancer treatment strategies.

📚 Publications Top Notes:

  1. 🧬 Targeting the VIP-VPAC Pathway in Melanoma Models Inhibits Tumor Growth and Liver Metastasis

  2. 🧫 VPAC2 Receptor Signaling Promotes Growth and Immunosuppression in Pancreatic Cancer

  3. 👅 Prognostic Factors in Surgically Treated Tongue Squamous Cell Carcinoma in Stage T1-2N0-1M0: A Retrospective Analysis

  4. 🔁 PVT1 Promotes Cancer Progression via MicroRNAs

  5. 🌀 Circular RNAs (circRNAs) in Cancer

  6. ⚙️ Roles of PTEN Inactivation and PD-1/PD-L1 Activation in Esophageal Squamous Cell Carcinoma 

📝 Conclusion:

Dr. Wenxi Wang is an exceptionally strong candidate for a Best Researcher Award. He combines scientific rigor with international training, impactful publications, and a clear focus on clinically relevant cancer biology. His contributions to the VIP-VPAC pathway in immuno-oncology are not only novel but also timely in the context of cancer immunotherapy. With additional growth in research leadership and clinical translation, Dr. Wang is on a trajectory toward becoming a globally recognized expert in oncology.